Organisation paid for research Program year 2021 Source: CMS Open Payments

Wolverine Clinic Trials

Neither a doctor nor a teaching hospital

Research payments

$587,008

62 payments

Through program year 2021, Wolverine Clinic Trials is reported as receiving $587,008 in research payments, across 62 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$5,250	3
2020	Research	$581,758	59

Breakdown

Who paid Research payments · program years 2020–2021

Janssen Research & Development, LLC $587,008 62 payments

Studies the money was for Research payments · program years 2020–2021

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa $569,420 56 payments
Dermatitis A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Atopic Dermatitis $12,338 3 payments
A Phase II Randomized Double Blind Placebo Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa $2,750 2 payments
Dermatitis A Phase II Randomized Double Blind Placebo Controlled Study of Bermekimab in Patients with Moderate to Severe Atopic Dermatitis $2,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.